表紙
市場調查報告書

連續性腎替代性治療市場:各種模式,各產品,不同治療,產業分析報告,各地區預測,各用途可能性,競爭市場佔有率,預測

Continuous Renal Replacement Therapy Market Size By Modality, By Product, By Therapy Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025

出版商 Global Market Insights Inc. 商品編碼 752457
出版日期 內容資訊 英文 160 Pages
商品交期: 2-3個工作天內
價格
連續性腎替代性治療市場:各種模式,各產品,不同治療,產業分析報告,各地區預測,各用途可能性,競爭市場佔有率,預測 Continuous Renal Replacement Therapy Market Size By Modality, By Product, By Therapy Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 - 2025
出版日期: 2019年08月16日內容資訊: 英文 160 Pages
簡介

本報告提供全球連續性腎替代性治療市場相關調查,彙整市場概要和各市場區隔趨勢,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法

第2章 摘要整理

第3章 產業趨勢

  • 產業市場區隔
  • 產業趨勢
  • 產業影響力
  • 成長可能性分析
  • 波特分析
  • 法律規範趨勢
  • 競爭環境
  • PESTEL分析

第4章 各種模式市場

  • 主要市場區隔趨勢
  • 持續性靜脈血液過濾
  • 持續性靜脈血液過濾透析
  • 持續性靜脈血液透析機
  • 持續性超過濾

第5章 各產品市場

  • 主要市場區隔趨勢
  • 設備
  • 消耗品

第6章 不同治療市場

  • 主要市場區隔趨勢
  • 腎臟
  • 非腎臟

第7章 各地區市場

  • 主要市場區隔趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 企業簡介

  • 旭化成株式會社
  • B.BraunMelsungen
  • Baxter International Inc.
  • Fresenius Medical Care
  • Infomed
  • Medica
  • Medical Components
  • Medites
  • Medtronic
  • 日機裝株式會社
  • Nxtstage
  • TORAY株式會社
目錄
Product Code: 2998

Continuous Renal Replacement Therapy Market will exceed USD 1.4 billion by 2025; as per a new research report.

Increasing prevalence of diabetes across the globe will prove beneficial for market growth over the forecast period. Diabetes is a leading factor contributing to renal failures that augment demand for CRRT. Diabetes disrupts the blood vessels in the kidney that adversely affects its functioning. Additionally, people suffering from type 2 diabetes have a higher risk of acquiring renal disorders. As a result, diabetic people prominently rely on continuous renal replacement therapy that will accelerate market growth in the forthcoming future.

The growing geriatric population especially in developed regions such as North America and Europe will surge the demand for advanced therapies over the analysis timeframe. The geriatric population is more susceptible to numerous disorders that rise the morbidity rate and makes them vulnerable to kidney disorders or renal failures. The prominent aged population suffers from acute kidney failures that augment demand for continuous renal replacement therapy, thereby propelling industry growth. However, complexities associated with CRRT may hinder market growth to a certain extent.

Continuous venovenous hemodialysis (CVVHD) segment was accounted for more than USD 410 million in 2018 and it is anticipated to witness substantial growth in the forthcoming future. Continuous venovenous hemodialysis is an efficient treatment for patients suffering from acute renal failure. Additionally, advanced therapies generally have technical advantages and are primarily suitable for the geriatric population. Also, CRRT offers substantial solute clearance that rises its preference thereby propelling segment growth.

Consumables segment of the continuous renal replacement therapy market is anticipated to witness more than 7.0% growth over the analysis timeframe. Consumables required for continuous renal replacement therapy are of superior quality and cost-effective. Furthermore, consumables utilized during CRRT treatment need to be replaced after every step to prevent contamination. Recycled consumables such as fistula needles may threat a patient's life. As a result, the high replacement rate of consumables will propel its demand that will stimulate segment growth in the near future.

The non-renal segment was valued around USD 180 million in 2018 and it is anticipated to witness significant growth during the analysis timeframe. Non-renal disorders such as sepsis and inflammatory syndromes can be cured with continuous renal replacement therapy, thereby propelling its demand in the coming years. Additionally, CRRT therapies have a pivotal role in removing mediators from blood circulation. As a result, the growing usage of CRRT in treating several non-renal disorders will favor segment growth over the forecast period.

Europe continuous renal replacement therapy market is anticipated to witness around 6% CAGR throughout the analysis timeframe. The increasing number of baby boomers susceptible to chronic diseases will prove beneficial for regional market growth. Also, growing incidences of diabetes across the region will fuel demand for continuous renal replacement therapy. The aforementioned factors will accelerate regional growth in coming years.

Some of the notable competitive players operating in the continuous renal replacement therapy market are B.Braun Melsungen, Fresenius Medical Care, Medical Components, Nxtstage, Asahi Kasei Corporation, Infomed, Medites, Medica, NikkisoToray, Medtronic and Baxter International. These companies are adopting several strategic activities such as collaborations, product launches, geographical expansions, mergers, and acquisitions. These activities will enable companies to garner more market share in the global market. For instance, in September 2017, B. Braun launched next-generation dialyzer Xeyonta for the U.S market. The advanced technology employed in the device helps in removing a higher amount of toxins from the patient's blood. Thus, increasing number of product launches will help the company to expand its product base and geographical footprint.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Continuous renal replacement therapy industry 360 degree synopsis, 2014 - 2025
    • 2.1.1. Business trends
    • 2.1.2. Modality trends
    • 2.1.3. Product trends
    • 2.1.4. Therapy trends
    • 2.1.5. Regional trends

Chapter 3. Continuous Renal Replacement Therapy Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2014 - 2025
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Growing incidences renal diseases in emerging economies in Asia Pacific
      • 3.3.1.2. High prevalence of diabetes in Europe & MEA
      • 3.3.1.3. Rising geriatric population more susceptible to kidney failure globally
      • 3.3.1.4. R&D expenditures by key industry players in North America & Europe
    • 3.3.2. Industry pitfalls and challenges
      • 3.3.2.1. High cost of CRRT
      • 3.3.2.2. Complications associated with renal replacement therapy
  • 3.4. Growth potential analysis
    • 3.4.1. By modality
    • 3.4.2. By product
    • 3.4.3. By therapy
  • 3.5. Porter's analysis
  • 3.6. Technology landscape
  • 3.7. Competitive landscape, 2018
    • 3.7.1. Strategy dashboard
  • 3.8. PESTEL analysis

Chapter 4. Continuous Renal Replacement Therapy Market, By Modality

  • 4.1. Key segment trends
  • 4.2. Continuous Venovenous Hemofiltration (CVVH)
    • 4.2.1. Market size, by region, 2014-2025 (USD Million)
  • 4.3. Continuous Venovenous Hemodiafiltration (CVVHDF)
    • 4.3.1. Market size, by region, 2014-2025 (USD Million)
  • 4.4. Continuous Venovenous Hemodialysis (CVVHD)
    • 4.4.1. Market size, by region, 2014-2025 (USD Million)
  • 4.5. Slow Continuous Ultrafiltration (SCUF)
    • 4.5.1. Market size, by region, 2014-2025 (USD Million)

Chapter 5. Continuous Renal Replacement Therapy Market, By Product

  • 5.1. Key segment trends
  • 5.2. Instruments
    • 5.2.1. Market size, by region, 2014-2025 (USD Million)
  • 5.3. Consumables
    • 5.3.1. Market size, by region, 2014-2025 (USD Million)

Chapter 6. Continuous Renal Replacement Therapy Market, By Therapy

  • 6.1. Key segment trends
  • 6.2. Renal
    • 6.2.1. Market size, by region, 2014-2025 (USD Million)
  • 6.3. Non-renal
    • 6.3.1. Market size, by region, 2014-2025 (USD Million)

Chapter 7. Continuous Renal Replacement Therapy Market, By Region

  • 7.1. Key regional trends
  • 7.2. North America
    • 7.2.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.2.2. Market size, by modality, 2014 - 2025 (USD Million)
    • 7.2.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.2.4. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.2.5. U.S.
      • 7.2.5.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.2.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.5.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.2.6. Canada
      • 7.2.6.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.2.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.2.6.3. Market size, by therapy, 2014 - 2025 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.3.2. Market size, by modality, 2014 - 2025 (USD Million)
    • 7.3.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.3.4. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.3.5. Germany
      • 7.3.5.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.3.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.5.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.3.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.6.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.3.7. UK
      • 7.3.7.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.3.7.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.7.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.3.8. Italy
      • 7.3.8.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.3.8.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.8.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.3.9. Spain
      • 7.3.9.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.3.9.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.9.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.3.10. Russia
      • 7.3.10.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.3.10.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.3.10.3. Market size, by therapy, 2014 - 2025 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.4.2. Market size, by modality, 2014 - 2025 (USD Million)
    • 7.4.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.4.4. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.4.5. China
      • 7.4.5.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.4.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.5.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.4.6. Japan
      • 7.4.6.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.4.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.6.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.4.7. India
      • 7.4.7.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.4.7.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.7.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.4.8. Australia
      • 7.4.8.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.4.8.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.8.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.4.9. South Korea
      • 7.4.9.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.4.9.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.4.9.3. Market size, by therapy, 2014 - 2025 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.5.2. Market size, by modality, 2014 - 2025 (USD Million)
    • 7.5.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.5.4. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.5.5. Brazil
      • 7.5.5.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.5.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.5.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.5.6. Mexico
      • 7.5.6.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.5.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.6.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.5.7. Argentina
      • 7.5.7.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.5.7.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.5.7.3. Market size, by therapy, 2014 - 2025 (USD Million)
  • 7.6. MEA
    • 7.6.1. Market size, by country, 2014 - 2025 (USD Million)
    • 7.6.2. Market size, by modality, 2014 - 2025 (USD Million)
    • 7.6.3. Market size, by product, 2014 - 2025 (USD Million)
    • 7.6.4. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.6.5. Saudi Arabia
      • 7.6.5.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.6.5.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.5.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.6.6. South Africa
      • 7.6.6.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.6.6.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.6.3. Market size, by therapy, 2014 - 2025 (USD Million)
    • 7.6.7. UAE
      • 7.6.7.1. Market size, by modality, 2014 - 2025 (USD Million)
      • 7.6.7.2. Market size, by product, 2014 - 2025 (USD Million)
      • 7.6.7.3. Market size, by therapy, 2014 - 2025 (USD Million)

Chapter 8. Company Profiles

  • 8.1. Asahi Kasei Corporation
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. B.Braun Melsungen
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Baxter International Inc.
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. Fresenius Medical Care
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. Infomed
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Medica
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. Medical Components
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. Medites
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Medtronic
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Nikkiso
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Nxtstage
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Toray
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis

Data Tables

  • TABLE 1. Continuous renal replacement therapy industry 360 degree synopsis, 2014 - 2025
  • TABLE 2. Continuous renal replacement therapy market, 2014-2025 (USD Million)
  • TABLE 3. Continuous renal replacement therapy market, 2014-2025 (USD Million)
  • TABLE 4. Continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 5. Continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 6. Continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 7. Continuous renal replacement therapy market, by region, 2014-2025 (USD Million)
  • TABLE 8. Industry impact forces
  • TABLE 9. Instruments market size, by region, 2014 - 2025 (USD Million)
  • TABLE 10. Consumables market size, by region, 2014 - 2025 (USD Million)
  • TABLE 11. Continuous venovenous hemofiltration market size, by region, 2014 - 2025 (USD Million)
  • TABLE 12. Continuous venovenous hemodiafiltration market size, by region, 2014 - 2025 (USD Million)
  • TABLE 13. Continuous venovenous hemodialysis market size, by region, 2014 - 2025 (USD Million)
  • TABLE 14. Slow continuous ultrafiltration market size, by region, 2014 - 2025 (USD Million)
  • TABLE 15. Renal therapy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 16. Non-renal therapy market size, by region, 2014 - 2025 (USD Million)
  • TABLE 17. North America continuous renal replacement therapy market size, by country, 2014-2025(USD Million)
  • TABLE 18. North America continuous renal replacement therapy market size, by modality, 2014-2025, (USD Million)
  • TABLE 19. North America continuous renal replacement therapy market size, by product, 2013-2017, (USD Million)
  • TABLE 20. North America continuous renal replacement therapy market size, by therapy,2014-2025, (USD Million)
  • TABLE 21. U.S. continuous renal replacement therapy market size, by modality, 2014-2025, (USD Million)
  • TABLE 22. U.S. continuous renal replacement therapy market size, by product,2014-2025, (USD Million)
  • TABLE 23. U.S. continuous renal replacement therapy market size, by therapy, 2014-2025, (USD Million)
  • TABLE 24. Canada continuous renal replacement therapy market size, by modality, 2014-2025, (USD Million)
  • TABLE 25. Canada continuous renal replacement therapy market size, by product,2014-2025, (USD Million)
  • TABLE 26. Canada continuous renal replacement therapy market size, by therapy, 2014-2025, (USD Million)
  • TABLE 27. Europe continuous renal replacement therapy market size, by country, 2014-2025 (USD Million)
  • TABLE 28. Europe continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 29. Europe continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 30. Europe continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 31. Germany continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 32. Germany continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 33. Germany continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 34. UK continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 35. UK continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 36. UK continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 37. Italy continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 38. Italy continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 39. Italy continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 40. France continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 41. France continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 42. France continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 43. Spain continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 44. Spain continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 45. Russia continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 46. Russia continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 47. Russia continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 48. Asia Pacific continuous renal replacement therapy market size, by country, 2014-2025 (USD Million)
  • TABLE 49. Asia Pacific continuous renal replacement therapy market size, by country, 2014-2025 (USD Million)
  • TABLE 50. Asia Pacific continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 51. Asia Pacific continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 52. Asia Pacific continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 53. China continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 54. China continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 55. China continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 56. China continuous renal replacement therapy market, by end-user, 2014-2025 (USD Million)
  • TABLE 57. India continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 58. India continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 59. Japan continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 60. Japan continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 61. Japan continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 62. Japan continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 63. Australia continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 64. Australia continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 65. Australia continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 66. South Korea continuous renal replacement therapy market, by product, 2014-2025 (USD Million)
  • TABLE 67. South Korea continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 68. South Korea continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 69. Latin America continuous renal replacement therapy market size, by country, 2014-2025 (USD Million)
  • TABLE 70. Latin America continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 71. Latin America continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 72. Latin America continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 73. Mexico continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 74. Mexico continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 75. Mexico continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 76. Brazil continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 77. Brazil continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 78. Brazil continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 79. Argentina continuous renal replacement therapy market, by product, 2014-2025 (USD Million)
  • TABLE 80. Argentina continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 81. Argentina continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 82. MEA continuous renal replacement therapy market size, by country, 2014-2025 (USD Million)
  • TABLE 83. MEA continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 84. MEA continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 85. MEA continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 86. South Africa continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 87. South Africa continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 88. South Africa continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 89. Saudi Arabia continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 90. Saudi Arabia continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 91. Saudi Arabia continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)
  • TABLE 92. UAE continuous renal replacement therapy market, by modality, 2014-2025 (USD Million)
  • TABLE 93. UAE continuous renal replacement therapy market, by product,2014-2025 (USD Million)
  • TABLE 94. UAE continuous renal replacement therapy market, by therapy, 2014-2025 (USD Million)

Charts & Figures

  • FIG 1. Industry segmentation
  • FIG 2. Continuous renal replacement market, 2014 - 2025 (USD Million)
  • FIG 3. Growth potential analysis, by modality
  • FIG 4. Growth potential analysis, by product
  • FIG 5. Growth potential analysis, by therapy
  • FIG 6. Porter's analysis
  • FIG 7. Strategy dashboard
  • FIG 8. PESTEL analysis